TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
EMM Life Science AB
Closing information (x1000 EUR)
| Closing information | 2024/08 | 2023/08 | 2022/08 |
| Turnover |
2,851
|
2,304
|
2,595 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
843
|
367
|
197 |
| EBITDA |
835
|
183
|
204 |
| Total assets |
1,202
|
557
|
1,902 |
| Current assets |
1,196
|
549
|
1,029 |
| Current liabilities |
523
|
238
|
372 |
| Equity capital |
678
|
319
|
1,529 |
| - share capital |
9
|
8
|
9 |
| Employees (average) |
4
|
2
|
2 |
Financial ratios
| Fiscal year | 2024/08 | 2023/08 | 2022/08 |
| Solvency |
56.4%
|
57.3%
|
80.4% |
| Turnover per employee |
713
|
1,152
|
1,298 |
| Profit as a percentage of turnover |
29.6%
|
15.9%
|
7.6% |
| Return on assets (ROA) |
70.1%
|
65.9%
|
10.4% |
| Current ratio |
228.7%
|
230.7%
|
276.6% |
| Return on equity (ROE) |
124.3%
|
115.0%
|
12.9% |
| Change turnover |
444
|
-37
|
762 |
| Change turnover % |
18%
|
-2%
|
42% |
| Chg. No. of employees |
2
|
0
|
0 |
| Chg. No. of employees % |
100%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/08 | 2023/08 | 2022/08 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.